MIRAGEN THERAPEUTICS, INC. License Agreements

26 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated License Agreement between Paragon Therapeutics, Inc. and Viridian Therapeutics, Inc.
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
MA
2024
Seventh Amendment to License and Collaboration Agreement between Miragen Therapeutics, Inc. and Les Laboratoires Servier/Institut de Recherches Servier
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2018
Sixth Amendment to License and Collaboration Agreement between Miragen Therapeutics, Inc. and Les Laboratoires Servier
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2017
Technology License Agreement between Miragen Therapeutics, Inc. and Xencor, Inc. (December 16, 2020)
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
NY
2021
License Agreement between Viridian Therapeutics, Inc. and ImmunoGen, Inc. dated October 12, 2020
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
MA
2020
Amendment No. 1 to Amended and Restated License Agreement between Roche Innovation Center Copenhagen A/S and Miragen Therapeutics, Inc.
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2019
Fifth Amendment to License and Collaboration Agreement between Miragen Therapeutics, Inc. and Les Laboratoires Servier/Institut de Recherches Servier
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2017
Exclusive Patent License Agreement between The Brigham and Women's Hospital, Inc. and Miragen Therapeutics, Inc.
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
Fourth Amendment to License and Collaboration Agreement between Miragen Therapeutics, Inc. and Servier
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
Third Amendment to License and Collaboration Agreement between Miragen Therapeutics, Inc. and Les Laboratoires Servier/Institut de Recherches Servier
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
Second Amendment to License and Collaboration Agreement between Miragen Therapeutics, Inc. and Les Laboratoires Servier/Institut de Recherches Servier
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
First Amendment to License and Collaboration Agreement between Miragen Therapeutics, Inc. and Les Laboratoires Servier/Institut de Recherches Servier
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
License and Collaboration Agreement between Miragen Therapeutics, Inc. and Les Laboratoires Servier and Institut de Recherches Servier
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
Amended and Restated License Agreement between Miragen Therapeutics, Inc. and Santaris Pharma A/S (December 31, 2012)
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
Amendment No. 1 to License and Collaboration Agreement between miRagen Therapeutics, Inc. and T2Cure GmbH
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
License and Collaboration Agreement between Miragen Therapeutics, Inc. and T2Cure GmbH
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
Exclusive Patent License Agreement between The University of Texas System and Miragen Therapeutics, Inc.
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
Exclusive Patent License Agreement between The University of Texas System and Miragen Therapeutics, Inc.
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2016
License Agreement between University of Arkansas for Medical Sciences and Myeloma Health LLC
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2014
Patent Cost Reimbursement Certification Letter between Myeloma Health, LLC and University of Arkansas
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2014
Patent Cost Reimbursement Certification Letter between Myeloma Health LLC and University of Arkansas
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2014
Amendment No. 4 to License Agreement between University of Arkansas for Medical Sciences and Myeloma Health LLC
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2014
Amendment No. 3 to License Agreement between University of Arkansas and Myeloma Health LLC
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2014
Second Amendment to License Agreement between University of Arkansas for Medical Sciences and Myeloma Health LLC
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
AR
2014
First Amendment to License Agreement between University of Arkansas and Myeloma Health LLC
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2014
License Agreement between University of Arkansas for Medical Sciences and Myeloma Health LLC
License Agreements
MIRAGEN THERAPEUTICS, INC.
Biotechnology
2014